M.D. Anderson Cancer Center: all 3,044 studies

Page 20 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT03586661Phase 1
• Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent CancerActive, not recruitingNCT03583255Phase 2
• Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate CancerWithdrawnNCT03581500Phase 2
• CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell LymphomaWithdrawnNCT03579927Phase 1/2
• CD19-Specific T Cells Post AlloSCTTerminatedNCT03579888Phase 1
• M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast CancerTerminatedNCT03579472Phase 1
• Levorphanol as a Second Line Opioid in Reducing Pain in Patients With CancerTerminatedNCT03579446Early Phase 1
• Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerActive, not recruitingNCT03579316Phase 2
• Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell CancerCompletedNCT03575949Not applicable
• Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their PartnersActive, not recruitingNCT03575832Not applicable
• Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell CarcinomaSuspendedNCT03575611Phase 2
• Barriers Affecting Physical ActivityCompletedNCT03573375Not applicable
• Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before SurgeryActive, not recruitingNCT03565783Phase 2
• Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese ParticipantsActive, not recruitingNCT03546972Not applicable
• Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell CarcinomaActive, not recruitingNCT03541902Phase 2
• Developing an eLearning Program in Helping Spanish and Portuguese Speaking Cancer Care Providers During Tobacco Use CounsellingCompletedNCT03539991Not applicable
• Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous CarcinomaActive, not recruitingNCT03531645Phase 2
• A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 ImmunotherapyActive, not recruitingNCT03525873Phase 3
• Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast CancerCompletedNCT03524170Phase 1
• Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral BronchoscopyCompletedNCT03523689
• Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation TreatmentActive, not recruitingNCT03519451Not applicable
• Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisCompletedNCT03508570Phase 1
• REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast ReconstructionCompletedNCT03502512Not applicable
• Cycling in Preventing Colorectal Cancer in Participants With Lynch SyndromeCompletedNCT03495674Not applicable
• Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck CancerActive, not recruitingNCT03491176
• Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerCompletedNCT03473730Early Phase 1
• Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)Active, not recruitingNCT03460769
• Text Messages in Preventing Tobacco Use in Young AdultsCompletedNCT03457480Not applicable
• Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated GlioblastomaCompletedNCT03452930Phase 1
• Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar CancersCompletedNCT03452332Phase 1
• Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent SarcomaCompletedNCT03450122Phase 1
• LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue SarcomasActive, not recruitingNCT03449108Phase 2
• Comprehensive Lifestyle Change To Prevent Breast CancerActive, not recruitingNCT03448003Not applicable
• Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With CancerCompletedNCT03445572Not applicable
• Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual DiseaseActive, not recruitingNCT03441061Phase 2
• Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral NeuropathyWithdrawnNCT03436680Not applicable
• Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTActive, not recruitingNCT03435952Phase 1
• Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic CancerWithdrawnNCT03432676Phase 2
• Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid TumorsCompletedNCT03430882Phase 1
• An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast CancerActive, not recruitingNCT03429907Not applicable
• Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisCompletedNCT03426969Early Phase 1
• Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 1
• Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR StudyActive, not recruitingNCT03410043Phase 2
• Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With CirrhosisCompletedNCT03407001Early Phase 1
• Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic SyndromeTerminatedNCT03404193Phase 2
• ICU Triage Practices in a Cancer HospitalCompletedNCT03401411Not applicable
• Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis FungoidesActive, not recruitingNCT03398161Phase 2
• Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal AdenocarcinomaCompletedNCT03395847Early Phase 1
• Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerActive, not recruitingNCT03391869Phase 3
• A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer CenterCompletedNCT03390283
• Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With CancerCompletedNCT03360799
• Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate CancerTerminatedNCT03360721Phase 2
• Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast CancerActive, not recruitingNCT03359954Phase 2
• Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive CytologyCompletedNCT03330028Phase 1
• Effectiveness of Bronchoscopic Interventions for Malignant Airway ObstructionCompletedNCT03326570
• Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before SurgeryActive, not recruitingNCT03307616Phase 2
• IACS-010759 in Advanced CancersCompletedNCT03291938Phase 1
• Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal CancerCompletedNCT03290937Phase 1
• RCT of QPS vs General Information SheetActive, not recruitingNCT03287492Not applicable
• Daratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisCompletedNCT03283917Phase 1
• Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple MyelomaWithdrawnNCT03283046Phase 1
• Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell LymphomaActive, not recruitingNCT03282396Phase 2
• Glutamine PET Imaging Colorectal CancerTerminatedNCT03275974Phase 1
• Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPCCompletedNCT03263650Phase 2
• Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell TransplantCompletedNCT03259503Phase 1
• Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell TransplantActive, not recruitingNCT03247088Phase 1/2
• Mind-Body Intervention in Glioma CouplesActive, not recruitingNCT03244995Not applicable
• Investigating the Effect of Simulated Live Piano Music on Preoperative Cancer Patients, Health Care Providers and Hospital Volunteers Using Validated Questionnaires and Proteomic AnalysisWithdrawnNCT03239587
• Ibrutinib Plus Rituximab and Lenalidomide in Treating Elderly Participants With Newly Diagnosed Mantle Cell LymphomaWithdrawnNCT03232307Phase 2
• Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally AdvancedActive, not recruitingNCT03225664Phase 1/2
• Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal CancerActive, not recruitingNCT03224000Phase 2
• rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin ChemotherapyActive, not recruitingNCT03219502Not applicable
• Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell LymphomaCompletedNCT03219047Early Phase 1
• Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver SurgeryActive, not recruitingNCT03214510Phase 3
• Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT03207542Phase 2
• Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerCompletedNCT03207529Phase 1
• Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell LymphomasWithdrawnNCT03205891Phase 1
• Oral Supplementation to Enhance Recovery Pilot StudyCompletedNCT03204266Early Phase 1
• Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic CancerTerminatedNCT03203525Phase 1
• Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast CancerActive, not recruitingNCT03202316Phase 2
• Tu Salud Si Cuenta Intervention in Increasing Physical Activity and Healthy Eating Among Latino FamiliesActive, not recruitingNCT03199365Not applicable
• Your Health Matters! (Tu Salud ¡Si Cuenta!): Promoting Healthy Lifestyles in Latino FamiliesActive, not recruitingNCT03199209Not applicable
• Using Social Networks to Promote Physical Activity in African American and Hispanic WomenActive, not recruitingNCT03199196Not applicable
• PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic CancerActive, not recruitingNCT03187951Not applicable
• Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid CancerActive, not recruitingNCT03181100Phase 2
• Colorectal Cancer (CRC) Surveillance Tool: Cognitive and Pilot TestingCompletedNCT03180411
• The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) SymptomsWithdrawnNCT03177681Not applicable
• Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate CancerCompletedNCT03177460Phase 1
• Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain MetastasesActive, not recruitingNCT03175432Phase 2
• Effect of Physician Attire on Patients' Preference of PhysicianCompletedNCT03168763Not applicable
• 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsActive, not recruitingNCT03168737Phase 1
• Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck CancerSuspendedNCT03164460Phase 2
• Selumetinib and Olaparib in Solid TumorsActive, not recruitingNCT03162627Phase 1
• Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing TechniquesActive, not recruitingNCT03151564Not applicable
• Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic LeukemiaActive, not recruitingNCT03147612Phase 2
• Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell CancerCompletedNCT03144778Phase 1
• Decision Aid Website in Helping to Make Decisions About Fertility in Participants With CancerActive, not recruitingNCT03141437Not applicable
• Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory LeukemiaActive, not recruitingNCT03132454Phase 1
• Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN LossCompletedNCT03131908Phase 1/2
• Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLLActive, not recruitingNCT03128879Phase 2

← M.D. Anderson Cancer Center overview and focus areas